Latest AI and machine learning research in dementia for healthcare professionals.
BACKGROUND: Mild cognitive impairment is widely recognized as a high-risk state associated with a pr...
Early and accurate diagnosis of Alzheimer's disease (AD) remains a significant challenge due to the ...
BACKGROUND: Most people with dementia reside in the community and are cared for by family members. F...
Objective.Deep learning has significantly advanced low-count positron emission tomography (PET) deno...
This study aimed to investigate the prevalence of screening-positive mild cognitive impairment (s-MC...
Interventions targeting social and health-related risk factors are thought to reduce the risk of cog...
Whether individual-level cognitive trajectories in Parkinson's disease are predictable remains unres...
BACKGROUND: Early identification of autism spectrum disorder (ASD) is essential for improving develo...
Early detection and biological characterization of Alzheimer's disease (AD) remain challenging, as c...
Semi-quantitative positron emission tomography (PET) analysis, particularly Centiloid and CenTauRz s...
Artificial Intelligence (AI) has become integral to the research of neurological diseases due to the...
BACKGROUND: Dementia caregiving entails chronic, fluctuating stress with downstream risks to caregiv...
OBJECTIVE: This study uses bibliometric analysis and knowledge mapping methods to systematically exp...
As a progressive neurodegenerative disorder, Alzheimer's disease (AD) requires early and accurate di...
Neurodegenerative diseases, such as Mild Cognitive Impairment (MCI) and Alzheimer's, pose significan...
BACKGROUND: In an attempt to overcome the space-time limitations of traditional training we used a n...
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are described as a disease con...
BackgroundAlzheimer's disease (AD) is the most common cause of dementia whose prevalence is projecte...
Human languages are unique in their capacity to tell stories. Prior neuroimaging studies show that s...
BackgroundNeuropsychiatric symptoms (NPS) are common in Alzheimer's disease (AD) and mild cognitive ...
Accurate quantification of structurally similar metabolites as biomarkers in biofluids has remained ...